In-vitro evaluation of β-lactamase inhibition by latamoxef and imipenem

2Citations
Citations of this article
6Readers
Mendeley users who have this article in their library.
Get full text

Abstract

The in-vitro 50% inhibitory concentrations (IC50s) of latamoxef and imipenem against a set of plasmid-mediated β-lactamases including TEM-1, TEM-3, TEM-5 and TEM-10 were determined by an enzymatic method using nitrocefin as substrate. The IC50s of both antibiotics against extended-spectrum β-lactamases were below 0.2 mg/L. The conventional spectrum β-lactamase TEM-1 was not inhibited by either antibiotic at the highest concentration tested. Except for TEM-10 for which the IC50s of the two antibiotics were the same, imipenem showed significantly greater activity than latamoxef against TEM-3 and TEM-5. Clavulanic acid taken as a control demonstrated greater and wider inhibitory activity, but on the other hand it has no significant antibiotic activity.

Cite

CITATION STYLE

APA

Sotto, A., Brunschwig, C., O’Callaghan, D., Ramuz, M., & Jourdan, J. (1996). In-vitro evaluation of β-lactamase inhibition by latamoxef and imipenem. Journal of Antimicrobial Chemotherapy, 37(4), 697–701. https://doi.org/10.1093/jac/37.4.697

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Save time finding and organizing research with Mendeley

Sign up for free